Synopsis of recent research by authors named "Zhi-Juan Hu"
- Zhi-Juan Hu's recent research primarily focuses on the effects of pharmacological agents, particularly sodium-glucose co-transporter 2 (SGLT2) inhibitors, on renal outcomes in patients with type 2 diabetes mellitus and chronic kidney disease, highlighting the need for systematic evaluation of these effects.
- The author has also explored bioactive compounds derived from natural sources, such as staurosporine derivatives from marine Streptomyces, emphasizing their potential medicinal properties and structure elucidation through advanced spectroscopic techniques.
- Additional studies conducted by Hu investigate the roles of specific signaling pathways and molecular interactions in cancer pathology and metabolic diseases, including the CCL20/CCR6 and ERK signaling pathway in lung adenocarcinoma, and the impact of transcription factor ATF4 on lipogenesis in liver cells, underscoring the intersection of metabolism and disease biology.
